Yanai, H. (2025) “Adenosine Monophosphate-Activated Protein Kinase Activation and Mammalian Target of Rapamycin Complex 1 Inhibition: A Mechanistic Rationale for Anti-Aging Therapy in Type 2 Diabetes”, Journal of Clinical Medicine Research, 17(9), pp. 469–489. doi:10.14740/jocmr6370.